Invesaro

Stocks RDCM Financial statements

Financial statements

RADCOM LTD financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data RADCOM LTD files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue29.537.234.13337.640.346.151.66171.5
Cost of revenue8.9810.58.879.9210.811.412.713.815.717.2
Gross profit20.526.725.223.126.828.933.337.845.354.3
Research and development8.0510.615.518.619.220.321.519.618.720.2
Selling and marketing8.531111.410.59.7110.412.314.617.819.7
General and administrative4.524.193.393.673.844.184.465.066.416.44
Operating expenses19.424.228.730.931.434.437.538.542.246
Operating income1.122.6-3.49-7.84-4.58-5.49-4.11-0.663.098.3
Interest expense0.02
Interest income4.34.694.97
Other non-operating income0.820.391.141.170.810.352.024.564.12
Pre-tax income1.942.98-2.35-6.66-3.77-5.14-2.13.97.212.6
Income tax0.020.080.060.170.220.120.160.180.230.6
Net income1.922.9-2.42-6.83-3.99-5.26-2.263.716.9712
EBITDA1.413.13-2.83-7.08-3.88-4.95-3.64-0.043.779
EPS, basic0.180.24-0.18-0.50-0.29-0.37-0.160.250.440.74
EPS, diluted0.180.23-0.18-0.50-0.29-0.37-0.160.240.430.71
Shares, basic (weighted)10.41213.613.814.114.515.115.716.3
Shares, diluted (weighted)10.812.413.613.813.914.114.515.316.216.8

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents42.922.6626.213.511.99.5310.919.230.5
Short-term investments4063.155.458.664.171.375.479.4
Receivables4.3920.320.41112.41011.113.41920.2
Inventory0.621.20.251.360.540.930.80.251.670.32
Other current assets1.962.691.771.541.441.961.931.591.822.04
Total current assets49.986.884.483.283.483.587.597.4117133
Property, plant and equipment1.521.921.831.671.311.261.010.80.880.99
Lease right-of-use assets5.842.951.812.461.653.422.9
Goodwill1.241.241.24
Intangible assets1.711.371.03
Total assets54.691.989.596.493.691.7101108131145
Accounts payable2.821.831.562.451.592.652.712.642.462.63
Accrued liabilities2.083.432.281.361.723.363.266.625.365.19
Deferred revenue2.592.60.270.833.151.476.851.1
Short-term debt40
Total current liabilities1111.97.5312.714.916.222.820.127.923
Lease liabilities4.972.010.891.450.562.442.14
Total liabilities14.415.511.122.521.621.528.22534.930.9
Paid-in capital98.3131136138140143149155161167
Retained earnings-56.1-53.2-55.3-62.1-66.1-71.4-73.6-69.9-62.9-51
Other comprehensive income-2.56-2.52-2.61-2.63-2.66-2.62-2.91-3.03-2.91-2.92
Shareholders' equity40.176.478.573.97270.272.882.595.7114
Total equity40.176.478.573.97270.272.882.595.7114
Total liabilities and equity54.691.989.596.493.691.7101108131145
Shares outstanding11.613.413.713.813.914.214.715.315.916.6

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income1.922.9-2.42-6.83-3.99-5.26-2.263.716.9712
Depreciation and amortization0.290.540.660.750.70.540.480.620.680.69
Stock-based compensation2.472.222.122.232.173.365.176.126.16.12
Change in receivables-0.33-15.90.019.3-1.652.41-1.04-2.33-5.64-1.2
Change in inventory0.79-0.560.9-1.140.81-0.410.160.55-1.421.27
Change in payables1.27-1.15-0.181-0.77
Cash from operations9.45-10.6-1.956.84-0.0526.024.7111.414.6
Capital expenditures-1.33-0.79-0.66-0.7-0.43-0.44-0.15-0.23-0.43-0.38
Acquisitions-2.48
Cash from investing-1.33-40.839.3-62.67.6-3.5-8.43-3.59-2.74-4.01
Stock issued21.30.892.130.020.34
Cash from financing25.731.12.130.027.6-3.5-8.430.34
Exchange rate effect0.35-0.02-0.15-0.03-0.2-0.1
Net change in cash34.2-20.339.4-55.87.35-1.6-2.421.378.3511.2
Free cash flow8.12-11.4-2.616.14-0.481.575.874.471114.2
Income taxes paid0.020.080.030.120.130.080.10.190.280.49

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $10.36 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin76.0%Gross profit / revenue.
Operating margin11.6%Operating income / revenue.
EBITDA margin12.6%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin17.6%Pre-tax income / revenue.
Net margin16.8%Net income / revenue.
FCF margin19.9%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin20.4%Cash from operations / revenue.
Effective tax rate4.7%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)11.4%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)8.7%Net income / average total assets.
Return on invested capital (ROIC)9.9%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue28.3%Research and development expense / revenue.
Stock-based pay / revenue8.6%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue0.5%Capital expenditures / revenue.
D&A / revenue1.0%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y17.2%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y15.8%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y13.7%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y20.0%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y17.7%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y15.2%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y169.0%Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y138.9%EBITDA vs the same period a year earlier. Only from a positive base.
Net income growth, 1y72.1%Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y65.1%EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y28.3%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y34.4%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow growth, 1y29.8%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y34.3%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y19.3%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y16.2%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y9.6%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y11.0%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y12.8%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y9.1%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y4.2%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y5.0%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y3.9%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio5.75xCurrent assets / current liabilities.
Quick ratio5.65x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio4.77x(Cash + short-term investments) / current liabilities.
Liabilities / assets21.3%Total liabilities / total assets.
Working capital$109.5MCurrent assets - current liabilities.
Goodwill and intangibles / assets1.6%(Goodwill + intangible assets) / total assets.
Tangible book value$111.8MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.52xRevenue / average total assets.
Fixed asset turnover76.6xRevenue / average property, plant and equipment.
Inventory turnover17.3xCost of revenue / average inventory.
Days inventory21 days365 x average inventory / cost of revenue.
Receivables turnover3.64xRevenue / average receivables.
Days sales outstanding100 days365 x average receivables / revenue.
Days payables54 days365 x average accounts payable / cost of revenue.
Cash conversion cycle67 daysDays inventory + days sales outstanding - days payables.
FCF conversion118.6%Free cash flow / net income, when net income is positive.
Capex / operating cash flow2.6%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$0.71Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic$0.74Net income per basic share, as reported (split-adjusted).
Revenue per share$4.25Revenue / diluted weighted shares.
FCF per share$0.84Free cash flow / diluted weighted shares.
Operating cash flow per share$0.87Cash from operations / diluted weighted shares.
Book value per share$6.88Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$6.74Tangible book value / shares outstanding.
Cash per share$6.62(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$172.9MShare price x shares outstanding.
Enterprise value$63.0MMarket cap + total debt - cash - short-term investments.
P/E14.4xMarket cap / net income. Only when net income is positive.
P/S2.42xMarket cap / revenue.
P/B1.52xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book1.55xMarket cap / tangible book value, when positive.
P/FCF12.2xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF11.8xMarket cap / cash from operations, when positive.
EV/Sales0.88xEnterprise value / revenue.
EV/EBIT7.59xEnterprise value / operating income, when both are positive.
EV/EBITDA7.00xEnterprise value / EBITDA, when both are positive.
EV/FCF4.43xEnterprise value / free cash flow, when both are positive.
FCF yield8.2%Free cash flow / market cap.
Earnings yield6.9%Net income / market cap (the inverse of P/E).
What was RADCOM LTD's revenue in fiscal 2025?

RADCOM LTD reported revenue of $71.5M for fiscal 2025, 17.2% higher than the year before.

Was RADCOM LTD profitable in fiscal 2025?

Yes. Net income was $12.0M, a net margin of 16.8%.

How much free cash flow did RADCOM LTD generate in fiscal 2025?

Cash from operations of $14.6M minus capital expenditures of $384.0K left free cash flow of $14.2M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to RADCOM LTD